National Gaucher Foundation - Gaucher Disease
Slideshow Image 1
Slideshow Image 2
Slideshow Image 3

Past Gaucher Disease News

Dec 18, 2013 - PCORI comments from NGF CEO, Rhonda P. Buyers

Dec 18, 2013 - Genetic Alliance team among PCORI funding recipients to establish the National Patient Centered Clinical Research Network

Dec 18, 2013 - Genzyme and NORD Establish Program to Help Undiagnosed Patients with Rare Diseases

Dec 17, 2013 - Overworked Cellular Machines May Explain Gaucher Disease Link to Parkinson's Disease

Dec 12, 2013 - FDA Grants Priority Review for Genzyme’s Cerdelga™ (eliglustat), an Investigational Oral Therapy for Gaucher Disease

Dec 8, 2013 - Pfizer Brings New Programs and Resources to the Gaucher Community!

Dec 8, 2013 - Pfizer Brings Together Jewish Community Leaders To Raise Broad Awareness of Gaucher Disease

Dec 6, 2013 - Research and Markets: Global Gaucher's Disease Pipeline Highlights - 2014

Oct 14, 2013 - Protalix BioTherapeutics Announces Positive Phase I Clinical Trial Results for Oral GCD in Gaucher Disease Patients

Oct 2, 2013 - Leanne Mullen Gaucher Story The Hammonton Gazette

Sep 29, 2013 - Global Genes | RARE Project

Sep 5, 2013 - NORD Publishes New Online Physician's Guide to Gaucher Disease

Jul 1, 2013 - Genzyme Convenes 1st International Gaucher Conference on Bone Disease

Jun 5, 2013 - Pfizer Reaches Out to Russian Jewish Community to Educate About Gaucher Disease, the Most Common Jewish Genetic Disorder

Apr 29, 2013 - UPLYSO(TM) (alfataliglicerase) Approved in Mexico and Chile for the Treatment of Gaucher Disease

Apr 2, 2013 - Protalix BioTherapeutics Treats First Gaucher Patient in Phase I Study With PRX-112, an Orally-Administered Enzyme Treatment of Gaucher Disease

Mar 22, 2013 - A Scholarship Program for the LSD Community

Mar 18, 2013 - UPLYSO™ (alfataliglicerase) Approved in Brazil by ANVISA for the Treatment of Gaucher Disease

Mar 7, 2013 - Protalix BioTherapeutics Receives Approval to Initiate Phase I Study in Gaucher patients with PRX-112, an Orally-Administered Candidate for the Treatment of Gaucher Disease

Feb 15, 2013 - Genzyme Announces Positive New Data from Two Phase 3 Studies for Oral Eliglustat Tartrate for Gaucher Disease

Jan 25, 2013 - The Shire OnePath® Co-pay Assistance Program